InvestorsHub Logo
Followers 138
Posts 23699
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Sunday, 01/18/2015 10:29:30 AM

Sunday, January 18, 2015 10:29:30 AM

Post# of 2207
I expect that the second dose of TT-034 could show approximately a 10% reduction in the viral load of hepatitis C.

Then this spring the third dose level may show approximately a 31.6% reduction in the viral load of hepatitis C.

The this summer and autumn 2014 I expect that the fourth dose cohort should show a complete eradication of the hepatitis C from trial subjects in the fourth cohort.

Of course there is a planned fifth cohort that is 3.16 times higher than even the fourth cohort. The fifth cohort could be tried if necessary.

Good luck and GOD bless,

George
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BNTC News